Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Microenvironment”

297 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 297 results

Testing effectiveness (Phase 2)Ended earlyNCT04880382
What this trial is testing

Integrative Analysis of Tumor Microenvironment and Optimization of Immunotherapy Duration in NSCL Cancer Patients

Who this might be right for
Non Small Cell Lung Cancer
Institut Bergonié 8
Not applicableLooking for participantsNCT04658303
What this trial is testing

Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma

Who this might be right for
Melanoma
Yana Najjar 20
Not applicableUnknownNCT06250010
What this trial is testing

Immunotolerance in Endometrial Cancer and at the Maternal-fetal Interface: Immunological Profiling of the Tumor Microenvironment in Risk Stratification of Recurrence

Who this might be right for
Endometrial Cancer
Regina Elena Cancer Institute 30
Testing effectiveness (Phase 2)Looking for participantsNCT06794372
What this trial is testing

[68Ga]Ga-FAPI-46 in Staging of Head and Neck Carcinomas

Who this might be right for
Head and Neck Squamous Cell Carcinoma HNSCC
John O. Prior 20
Testing effectiveness (Phase 2)Ended earlyNCT03891173
What this trial is testing

L-DOS47 in Combination With Vinorelbine/Cisplatin in Lung Adenocarcinoma

Who this might be right for
Lung Adenocarcinoma
Helix BioPharma Corporation 9
Not applicableLooking for participantsNCT05941234
What this trial is testing

Stem Cell Analysis, Omics (Including Immunomics) and Artificial Intelligence in Glioblastoma

Who this might be right for
Glioblastoma, IDH-wildtype
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 120
Not applicableNot Yet RecruitingNCT06764537
What this trial is testing

Evaluation of in Vitro Antitumor Activity of GD2 CAR-T Cells in Glioblastoma

Who this might be right for
Glioblastoma
Central Hospital, Nancy, France 18
Not applicableLooking for participantsNCT06518382
What this trial is testing

Tumor-microenvironment Spatial Interaction to Identify Markers of Resistance to Therapy in HER2+ Breast Cancer Patients

Who this might be right for
HER2-positive Breast Cancer
Giampaolo Bianchini 10
Not applicableStudy completedNCT04694846
What this trial is testing

Effectiveness of an Enhanced Tobacco Intervention Protocol Compared to Standard Treatment in Helping Head and Neck and Lung Cancer Patients Starting Treatment to Reduce Cigarette Use

Who this might be right for
Lung Non-Small Cell CarcinomaHead and Neck Squamous Cell Carcinoma
Thomas Jefferson University 19
Not applicableLooking for participantsNCT07240207
What this trial is testing

Dissecting Tumour MicroenvirOnment in Solid Paediatric Tumour to Improve Adoptive Cell Therapy

Who this might be right for
Pediatric Solid Tumors
Fondazione IRCCS Policlinico San Matteo di Pavia 44
Not applicableLooking for participantsNCT07354971
What this trial is testing

IMMUNO-FIT Observational Study

Who this might be right for
NeoplasmsImmunotherapyPhysical Fitness+2 more
University Hospital Southampton NHS Foundation Trust 67
Not applicableUnknownNCT05789498
What this trial is testing

Investigating the Biomarkers in Tumor and Peripheral Blood to Evaluate the Efficacy of Cancer Immunotherapy in Chest Cancer Patients

Who this might be right for
Lung CancerEsophageal Cancer
Zhao Jun 60
Testing effectiveness (Phase 2)Ended earlyNCT04203641
What this trial is testing

L-DOS47 Plus Doxorubicin in Advanced Pancreatic Cancer

Who this might be right for
Pancreas Cancer
Helix BioPharma Corporation 28
Early research (Phase 1)Ended earlyNCT03670069
What this trial is testing

Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas

Who this might be right for
Metastatic LeiomyosarcomaMetastatic Synovial SarcomaMetastatic Undifferentiated Pleomorphic Sarcoma+15 more
Fred Hutchinson Cancer Center 27
Very early researchEnded earlyNCT01537861
What this trial is testing

Filgrastim in Treating Patients With Bortezomib-, Carfilzomib-, or IMID-Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Washington University School of Medicine 7
Not applicableLooking for participantsNCT06790797
What this trial is testing

Investigating the Biomarkers in Tumor and Peripheral Blood to Evaluate the Efficacy of Cancer Immunotherapy in Chest Cancer Patients

Who this might be right for
Lung CancerEsophageal Cancer
Zhao Jun 50
Not applicableUnknownNCT05515133
What this trial is testing

Correlation Between Psychological Stress and Disease Progression in Newly Diagnosed Glioblastoma Patients

Who this might be right for
Glioblastoma
Henan Provincial People's Hospital 60
Not applicableActive Not RecruitingNCT07564908
What this trial is testing

Correlation and Heterogeneity of the Immune Microenvironment and Histopathological Growth Patterns in Resectable Colorectal Cancer Liver Metastases

Who this might be right for
Colorectal Neoplasms
Meng Qiu 64
Not applicableLooking for participantsNCT06588205
What this trial is testing

Exploring the Clinical Impact of MYC Aberrations and Their Relationship With Microenvironment in Diffuse Large B Cell Lymphoma and High-Grade B Cell Lymphoma

Who this might be right for
Diffuse Large B Cell LymphomaHigh-grade B-cell LymphomaHigh Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
Fondazione Italiana Linfomi - ETS 200
Not applicableLooking for participantsNCT07180992
What this trial is testing

Quantitative and Qualitative Monocytes Analysis and Their Impact on CART Cells Reponse in Multiple Myeloma

Who this might be right for
Multiple MyelomaMonocytesCART Cells
Centre Hospitalier Universitaire, Amiens 25
Load More Results